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ABSTRACT 
The role of reactive oxygen species (ROS) in the regulation of hair follicle cycle 
and skin homeostasis is poorly characterized. ROS have been traditionally 
linked to human disease and ageing, but recent findings suggest that can also 
have beneficial physiological functions in vivo in mammals. To test this 
hypothesis, we transiently switched on in situ ROS production in mouse skin. 
This process activated cell proliferation in the tissue and, interestingly, in the 
bulge region of the hair follicle, a major reservoir of epidermal stem cells, 
promoting hair growth as well as stimulating tissue repair after severe burn 
injury. We further show that these effects were associated with a transient Src 
kinase phosphorylation at Tyr416 and with a strong transcriptional activation of 
the prolactin family 2 subfamily c of growth factors. Our results point to 
potentially relevant modes of skin homeostasis regulation and demonstrate that 
a local and transient ROS production can regulate stem cell and tissue function 
in the whole organism. 
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INTRODUCTION 
The skin is the largest organ in mammals, consisting of three layers, epidermis, 
dermis and hypodermis, with associated appendages, including hair follicles, 
sebaceous and sweat glands. The biology of epidermal stem cells in the skin is 
well known (Blanpain and Fuchs, 2009; Baker and Murray, 2012). In particular, 
the pilo-sebaceous unit (hair follicle and associated glands) and the hair follicle 
growth cycle constitute a very well characterized model to study the functional 
regulation of skin stem cells. The hair follicle is a complex mini-organ that 
invaginates from epidermal sheets of the skin into the dermis (Muller-Rover et 
al, 2001; Baker and Murray, 2012; Gilhar et al, 2012). Hair production is the 
result of a cyclic activity of the hair follicle alternating three sequential phases: 
anagen (growth), catagen (cessation and regression) and telogen (rest). The 
hair follicle is divided in two main regions depending on size variation rates 
through the hair cycle: permanent and cyclic regions. The upper permanent 
region, composed by the infundibulum, associated glands and the bulge, a 
major reservoir of hair follicle stem cells, regulates the activity of the dermal 
papilla in the cyclic region (Ramos et al, 2013). Activation of dermal papilla cells 
during the anagen phase promotes extensive cell proliferation and 
differentiation in the cyclic region, ultimately resulting in the formation and 
growing of the hair shaft. Skin components are constantly renewed by a stock of 
multipotent epidermal stem cells, located in the bulge region of the hair follicle 
and in the basal layer of the inter-follicular epithelium (Blanpain and Fuchs, 
2009; Baker and Murray, 2012). 
Important and well known molecular mechanisms, including Wnt/β-catenin, 
BMP/Tgfβ/Smad, PI3K/Akt and ERK/MAPK signalling pathways (Baker and 
Murray, 2012; Lopez-Pajares et al, 2013; Ramos et al, 2013), have key roles in 
the regulation of different aspects of skin stem cell and hair follicle function. 
However, skin homeostasis and the hair follicle cycle are extremely complex 
and multifactorial processes. Many of the interplaying mechanism that govern 
and/or modulate the functional output of these processes are not well 
characterized. In particular, the potential physiological role of reactive oxygen 
species (ROS) in the skin is largely unknown. 
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The generation of reactive oxygen species (ROS) as by-products of essential 
and efficient metabolic reactions, such as cellular respiration or oxidase activity, 
is an inevitable biochemical side-effect that can be extremely harmful for cell 
viability. The oxidative stress induced by the undesirable intracellular 
accumulation of ROS is a major cause of cell and tissue toxicity and it is 
associated with several human diseases, including neurodegenerative 
(Parkinson's, Alzheimer's and Huntington's diseases), psychiatric 
(schizophrenia and bipolar disorder) and cardiovascular (stroke and myocardial 
infarction) disorders (Pieczenik and Neustadt, 2007; Valko et al, 2007). ROS 
are also implicated in sickle cell disease and the fragile X and chronic fatigue 
syndromes (el Bekay et al, 2007; Pieczenik and Neustadt, 2007). The so called 
oxidative stress or free radical theory of aging proposes a causal link between 
gradual, time-dependent ROS production during the whole lifetime and aging of 
the organism, a controversial theory that remains the subject of intense debate 
(Perez et al, 2009; Speakman and Selman, 2011). 
Aerobic organisms have evolved powerful mechanisms to manage excess ROS 
production and are able to efficiently detoxify superoxide anions, 
hydroxyl radicals, hydrogen peroxide and organic hydroperoxides into harmless 
H2O and O2. These mechanisms are exemplified by the superoxide dismutase, 
catalase, and glutathione peroxidase enzymatic systems (Machlin and Bendich, 
1987; Fernandez and Videla, 1996; Mates and Sanchez-Jimenez, 1999). 
Interestingly, in the course of evolution, eukaryotic organisms have also 
developed systems to use ROS production for their own benefit. An example is 
the phagocyte, an essential cell player of the mammalian immune system that 
can produce radical oxygen and nitrogen species in a tightly controlled way to 
kill target pathogens (Klebanoff et al, 1983; Bylund et al, 2010). 
Accumulated evidence suggests that eukaryotic cells can also actively promote 
the production of small amounts of ROS as part of signalling pathways that 
regulate cell survival and proliferation (Droge, 2002, Chiarugi and Cirri, 2003, 
Bartosz, 2009, Sena and Chandel, 2012). Furthermore, it has been reported 
that exogenous ROS can regulate stem cell function in in vitro systems (Le 
Belle et al, 2010). An abnormal ROS production has been also linked to the 
deregulation of intestinal stem cell proliferation that occurs during colorectal 
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cancer initiation (Myant et al, 2013). These observations imply the existence of 
widespread ROS-dependent mechanisms for the regulation of cell function and 
tissue homeostasis. Here we have used the skin and the well characterized 
epidermal stem cell niche located in the bulge region of the mouse hair follicle 
as a working model to provide a proof-of-concept for the hypothesis that a 
transient modulation of in situ ROS levels can regulate skin homeostasis and 
stem cell function in a whole organism.  
RESULTS  
-Photodynamic treatment of mouse skin with mALA and red light induces 
a transient in situ ROS production in the tissue. 
To this end we first developed a reproducible method to promote a controlled 
and transient increase of ROS in the skin. High levels of intracellular ROS can 
be generated by a combination of light of an adequate wavelength and a 
photosensitizer (PS) in the presence of O2 (Juarranz et al, 2008). The resulting 
photodynamic effect (Figure S1a) is widely used as a powerful cell killing 
method in clinical practice (photodynamic therapy) for the treatment of several 
skin diseases, including cancer and infections. At present, 5-aminolevulinic acid 
(ALA) or its methyl derivative (mALA) in combination with red light is the most 
widely used photodynamic therapy in the clinic. These compounds are not PS 
per se, but function as precursors of the endogenous PS Protoporphyrin IX 
(PpIX) (Figure S1b) (Juarranz et al, 2008).  
We have previously demonstrated that mALA can be used to photo-generate 
tightly controlled low levels of intracellular ROS that are able to stimulate cell 
proliferation instead of cell death in cultured immortalized keratinocytes 
(Blazquez-Castro et al, 2012). Here, we have adapted this approach to mouse 
skin in vivo. We have evaluated irradiation doses from 2 to 10 J/cm2 and a fixed 
mALA concentration (25 mg Metvix®, mALA 160 mg/g cream). We found that 
topical application of mALA on mouse dorsal skin promoted an extensive 
production and accumulation of PpIX in the tissue, as revealed by the 
characteristic reddish fluorescence of this compound under blue light (407 nm) 
excitation (Figure 1a). As expected, mALA-dependent PpIX accumulation in the 
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skin followed by 2.5 J/cm2 irradiation with red light (636 nm) to complete the 
photodynamic treatment (mALA+Light) resulted in a significant increase of in 
situ ROS levels in the tissue (Figure 1b). A time-course analysis showed that 
relative ROS production was transient, returning to initial levels 100 min after 
irradiation (Figure 1b). To gain further detail on the distribution of generated 
ROS in the tissue we used the manageable mouse tail skin epithelium. 
Accordingly, experimental treatments and the localization of PpIX and ROS 
were evaluated ex vivo in whole pieces of the tissue. We established that 
incubation with mALA resulted in a significant accumulation of PpIX in the hair 
follicle (Figure 1c), followed by a notable production of ROS after 10 J/cm2 of 
red light irradiation (mALA+Light)  that was detected to some degree all over 
the epidermis, including IFE, infundibulum and sebaceous glands (Figure 1d). 
Notably, ROS signal rapidly disappeared or declined in most tissue locations, 
persisting for longer times in bulge cells (Figure 1d), which is the main niche or 
reservoir of epidermal stem cells in the skin. As these experiments were 
performed ex vivo to determine ROS localization, the time course of ROS 
production is not comparable to that observed in vivo in back skin. However, 
these results corroborate the transient nature of ROS production in the skin 
induced by our experimental approach, as well as the remarkable incidence on 
the bulge stem cell niche. 
To rule out deleterious effects of our protocol on cell and tissue viability we used 
different approaches. We analysed the formation of phosphorylated histone 
H2AX (pH2AX; also known as gammaH2AX) foci on the chromatin fibre that are 
associated with severe DNA damage (Yuan et al, 2010). No significant 
differences were observed in the number and distribution of pH2AX positive 
cells in the skin in samples irradiated with red light after mALA application, as 
compared to light control samples (Figure S2a). In sharp contrast, a strong 
increase in the number of cells showing pH2AX foci was observed in UV 
irradiated skin (Figure S2a). In the same way, we found that mALA+Light was 
unable to induce a noticeable increase in the number of apoptotic cells in the 
interfollicular epithelium or in the hair follicle (Figure S2b). Finally, we also 
evaluated whether our protocol could alter the incidence of skin tumour 
formation. We performed two series of experiments involving a single 
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mALA+Light (n=5) or a dual treatment in a 15 day period (n=3). In both cases, 
our results indicated that the mALA+Light treatment was completely safe and 
had no detectable or significant capacity to induce tumours in long-term 
experiments (up to 18 months). 
-Switching on in situ ROS production in the skin activates cell 
proliferation in epidermal and dermal layers and in the hair follicle stem 
cell niche. 
We next investigated the potential effects of the transient ROS increase induced 
by mALA+Light on the function of epidermal stem cells in the bulge region of 
the hair follicle. To this end, we first proceeded to identify stem cells as 
label retaining cells (LRC) in pulse and long-chase experiments with the 
nucleotide analogue 5-bromo-2´-deoxyuridine (BrdU) (Braun et al, 2003). We 
quantified the number of LRC in the bulge region of hair follicles at 7 weeks 
after birth, during which time hair follicles are in a refractory telogen or resting 
phase of the growth cycle and are insensitive to stimulatory signals (Muller-
Rover et al, 2001). We found that the transient in situ ROS production induced 
by mALA+Light activated the proliferation of bulge stem cells, promoting a 
significant increase in the number of BrdU labelled cells, that was first detected 
in the skin 2 days after the treatment (Figure 2a). This was associated with a 
strong and parallel increase in the number of dividing (Ki67 positive) cells in the 
bulge region (Figure 2b), indicating a proliferative response of the hair follicle 
stem cell niche. The number of BrdU labelled cells reverted to normal levels, as 
compared to control animals, 6 days after the treatment (Figure 2a), indicating 
the transient nature of the biochemical stimulus. These results were confirmed 
using a transgenic murine model in which GFP is expressed under the control 
of the keratin1- 15 promoter, a molecular marker of hair follicle epidermal stem 
cells (Morris et al, 2004). We found a significant increase of GFP positive cells 
in the bulge region of the hair follicle 2 days after mALA+Light that returned to 
normal levels 6 days after the treatment (Figure S3).  
We also observed that mALA+Light promoted a transient increase in the 
number of proliferating cells in the epidermal and dermal layers of the skin 
starting 2 days after the treatment and returning to normal levels by day 6 
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(Figure 2c; Figure S4a). This proliferative pulse was associated with a transient 
epidermal hyperplasia and a significant increase of dermal cellularity 2 days 
after treatment that disappeared by day 6 (Figure 2c; Figure S5c). A strong 
cornification was also observed in treated skin regions (Figure 2c), suggesting 
an overall acceleration of tissue turnover rate. These processes were not 
associated with histopathological features of inflammation or to the induction of 
molecular skin inflammation markers, like myeloperoxidase (MPO) (Figure 2c; 
Figures S4b, S5c). As a whole, these results are in agreement with our previous 
report in cultured keratinocytes (Blazquez-Castro et al, 2012) and indicate that a 
transient production of ROS in the skin promotes a transient proliferative 
response in the tissue that can activate the epidermal stem cell niche. 
-Switching on in situ ROS production in the skin stimulates hair growth 
and accelerates burn healing. 
We reasoned that the effect of mALA+Light on cell proliferation in the skin and, 
particularly, on stem cells contained in the hair follicle bulge region should 
produce a physiological response in the target tissue. Supporting this concept, 
we observed that mALA+Light strongly promoted hair growth after shaving 
stimulation during the refractory telogen phase (Figure 3a; Figure S5a). 
Importantly, the use of anti-oxidant compounds like ascorbic acid (AA) and 
N-acetylcysteine (NAC) abolished the differences in hair follicle growth rates 
induced by mALA+Light with respect to Light control skin (Figure 3a, b; Figure 
S5a). In agreement with this observation, anti-oxidant treatment significantly 
inhibited the production of ROS (Figure 3a, c) and the activation of cell 
proliferation (Figure 3d) induced by mALA+Light in the tissue. It is to note that, 
since we have observed inter-individual variations in the timing of hair growth in 
a day-range after the shaving stimulus, the comparisons between treated and 
control skin to quantify the mALA- phototreatment (mALA-PT) output were 
always established between different skin regions in the same mouse. 
Morphological features and Lef1 expression in the hair germ indicated that 
anagen entry occurred about 6 days after treatments in mALA+Light treated 
skin but not in the correlative Light treated skin controls or in non-treated skin 
(normal anagen, NA) showing spontaneous anagen entry (Figure 3e). As 
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expected, anagen entry was also observed in Light controls and non-treated 
skin about 10 days after treatments as a consequence of shaving stimulation, 
showing Lef1 expression and cell proliferation in the hair germ and dermal 
papilla (Figure 3e, f). However, mALA+Light treated skin consistently showed 
larger hair follicles with extensive cell proliferation at equivalent time points 
(Figure 3e, f). As a whole, these results indicate that a controlled and transient 
production of ROS in the skin can bypass the strong inhibitory signalling that 
occurs at refractory telogen of the hair follicle cycle, forcing the premature entry 
into the anagen growth phase.  
These results prompted us to investigate the ability of the transient ROS 
production to stimulate the regenerative potential of the skin. To this end, we 
performed a series of burn healing experiments. As shown in Figure 4, 
mALA+Light significantly accelerated the healing process after 2nd-degree burn 
injuries in the skin. Remarkably, this regenerative effect was associated with 
extensive cell proliferation in the bulge region of hair follicles adjacent to the 
burned area (Figure 4d), indicating the activation of this stem cell niche. Taken 
together, these results suggest that the activation of skin proliferation and of the 
hair follicle stem cell niche by a transient ROS production is a molecular signal 
able to stimulate different homeostatic programs in the skin, including hair 
growth and tissue regeneration.   
-Switching on in situ ROS production in the skin promotes a transient 
activating phosphorylation of cSrc kinase 
We next sought to investigate the molecular mechanisms underlying the 
stimulation of skin induced by mALA+Light treatments that, as demonstrated 
above, results in a transient proliferative wave 2 days after the treatment 
returning to normal levels by day 6. We focused on this time period and on 
signalling pathways known to have key roles in the activation of epidermal stem 
cell function and hair follicle growth, including Wnt/β-catenin, MAPK and 
PI3K/Akt signalling pathways. Interestingly, no changes in expression levels of 
either β-catenin or a metabolically stable, constitutively active form of this 
protein were detected after mALA+Light treatment (Figure 5a). Accordingly, no 
significant changes in the distribution of β-catenin were observed in 
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mALA+Light treated skin as compared to control samples, in both cases 
showing a major localization at the cell membrane and no nuclear translocation 
(Figure S6a), a key indicator of β-catenin dependent transcriptional activation. 
As described above (Fig. 3e) and as expected, Lef1 expression was found in 
hair follicles since day 6 and was remarkable on advanced anagen, around 10 
days after mALA-PT. In a similar way, no changes of phosphorylation at critical 
Thr/Tyr residues in different mitogen-activated protein kinases (MAPK) including 
JNK, p38 and ERK1/2, which are key indicators of signalling pathway activation, 
were observed after mALA+Light (Figure S6b). By contrast, a significant 
increase in phosphorylated Akt, similar to the increase observed in a 
neurosphere model (Le Belle et al, 2010), and a strong phosphorylation of Src 
kinase at Tyr416 were transiently detected 2 days after mALA+Light (Figure 
5a). Interestingly, Src protein showed an increased accumulation in the 
epidermis of mALA+Light skin samples 2 days after treatment that disappeared 
at day 6 (Figure 5b). These results are consistent with our previous 
observations indicating a role for Src in the ROS-dependent induction of cell 
proliferation in human keratinocytes (Blazquez-Castro et al, 2012).  
-Switching on in situ ROS production in the skin induces a transient 
transcriptional activation of prolactin family 2 subfamily c members. 
To get a deeper insight into the molecular mechanism underlying the 
ROS-dependent, Src-driven activation of the epidermal stem cell niche we 
performed a series of large-scale microarray analyses of mRNA expression, 
both in back and tail epidermis after mALA+Light as compared to control 
samples (GEO accession number GSE55135). Several genes showed 
significant transcriptional alterations 2 days after mALA+Light that were similarly 
modulated in tail and back epidermis (Table 1). It is to note that this large-scale 
analysis showed that mALA-PT was not associated with transcriptional profiles 
of inflammation or injury response. The transcriptional profiles of genes of 
interest were validated in all cases by qRT-PCR in dorsal skin at both 2 or 6 
days after mALA+Light (Figure 5c), revealing that the majority of genes 
transcriptionally altered at 2 days returned to normal expression levels 6 days 
after the treatment. In agreement with our previous observations, targets of 
Wnt/β-catenin signalling in the skin, such as Jag1, Ovol1 and Axin2, were 
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transcriptionally repressed 2 days after mALA+Light (Figure 5c). Interestingly, 
the strongest transient transcriptional activation induced by mALA+Light was 
observed for members of the prolactin family 2 subfamily c of growth factors. In 
particular, Prl2c3, also known as proliferin-2, showed a marked transient 
activation 2 days after switching on ROS production by mALA+Light (Table 1; 
Figure 5c). More surprisingly, we found a significantly increased expression of 
Prl2c3 protein in the skin associated with a strong nuclear localization in the 
hyperplastic interfollicular epidermis (Figure 5d). 
DISCUSSION 
Here we have shown that switching on in situ ROS production can regulate 
functional responses in a tissue through the stimulation of cell proliferation and 
of a stem cell niche. Our results are in agreement with recent reports showing a 
role for ROS during the stimulation of neural stem cells in vitro in a neurosphere 
model (Le Belle et al, 2010) and in the deregulation of intestinal stem cell 
proliferation that occurs during colorectal cancer initiation (Myant et al, 2013). In 
these studies an exogenous and/or continuous ROS supply or a systemic ROS 
depletion is used to evaluate a specific effect on a tissue or biological systems. 
As a complement to these studies, our experimental approach implies a local 
and transient activation of endogenous ROS production using the molecular 
machinery of the tissue. In this sense our results are in close consonance with 
the observation that a transient ROS production occurs during tail regeneration 
in Xenopus tadpoles (Love et al, 2013). In this report it is shown that activation 
of a regenerative signal, i. e. cutting the tadpole, is accompanied by a transient 
production of ROS. Here we demonstrate that a transient ROS switch on 
activates a regenerative signal. It has also been reported that the mitochondrial 
transcription factor A (TFAM) is required for normal hair follicle development 
and in vitro keratinocyte differentiation (Hamanaka et al, 2013), suggesting 
indirectly that mitochondrial ROS can have an important role in the regulation of 
skin function. Here we directly demonstrate that a transient generation of ROS 
in the mouse skin activates the hair follicle stem cell population, promoting hair 
growth in the refractory telogen phase and accelerating burn healing. In this 
context, it would be interesting to evaluate the clinical potential of a transient 
ROS production in situ in the skin to stimulate tissue homeostasis, for example, 
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to improve the healing process of small burns and chronic wounds or to activate 
hair growth or prevent hair loss in certain types of alopecia. 
We have found that switching on in situ ROS production by mALA-PT promotes 
a transient proliferative pulse in the tissue, including bulge cells, 2 days after the 
treatment. This proliferative burst results in extensive anagen development of 
hair follicles by days 8-10, showing extensive cell proliferation and Lef1 
expression particularly in the hair germ, and subsequent hair growth by days 
12-19 after mALA-PT. At day 2 most hair follicles are in telogen and, 
consequently, no evidence of β-catenin accumulation or transcriptional 
activation of Wnt/β-catenin signaling is observed. However, a significant 
activating phosphorylation of cSrc occurs at this time point. This result is 
particularly interesting, since no significant roles are usually assigned to Src 
kinase in relation to the regulation of skin stem cell function and/or the hair 
follicle growth cycle. However, it has been reported that Src protein expression 
and activity are regulated during normal hair follicle cycle (Serrels et al, 2009). 
In the same context, the molecular mechanisms regulating Src kinase activity 
by ROS in cultured cells are well characterized (Giannoni et al, 2010). These 
observations suggest that Src activity, independently or in combination with a 
controlled ROS production, can be an important partner in the skin signalling 
network, which merits further investigation. In this context, we hypothesize that 
mALA-PT induces 2 days after treatment an initial, cSrc-dependent, proliferative 
wave in the skin able to activate hair follicle stem cell niches. This activation 
results in standard, Lef1 dependent, anagen entry around 6 days after 
treatments. 
We have further shown that a transient ROS production switching on in the skin 
promotes a strong and unexpected transcriptional activation of prolactin family 2 
subfamily c gene members, particularly Prl2c3. Surprisingly, we found that 
Prl2c3 was significantly translocated to the nucleus in most cell layers in the 
hyperplastic epithelium after mALA+Light, suggesting that this hormone-
like protein can have nuclear functions. Interestingly, it has been reported that 
this mitogen is expressed in the hair follicle anagen growth phase (Fassett and 
Nilsen-Hamilton, 2001) and facilitates the expansion of hematopoietic stem cells 
ex vivo (Choong et al, 2003). The role of Prlc3 in the skin is currently under 
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investigation. In this context, the procedure presented here to transiently 
activate endogenous ROS production in the skin has proved to be an efficient 
tool not only to suggest a physiological role for ROS in vivo but also to identify 
new signalling pathways and factors potentially implicated in the regulation of 
skin homeostasis.
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MATERIALS AND METHODS 
Animals 
Seven-week-aged C57BL/6 mice, including the strain B6.Cg-Tg(Krt1-15-
EGFP)2Cot/J (Morris et al, 2004), were used. When possible, littermates were 
included in each experiment and comparisons were done between animals of 
the same sex. Both males and females were used in experiments using tail 
skin. Only females were used in experiments performed in back skin. All animal 
husbandry and experimental procedures were conducted in compliance with 
2010/63/UE European guideline or approved by the Subcommittee on Research 
Animal Care (IACUC) of Massachusetts General Hospital (Boston, MA), in 
accordance with the guidelines of the National Institutes of Health (NIH).  
Identification of Label Retaining Cells (LRC) in tail skin epithelium 
Long-term 5-bromo-2’-deoxyuridine (BrdU; Sigma-Aldrich) label retaining cells 
(LRC) were generated and characterized as previously described (Braun et al, 
2003). Briefly, ten-day-old mice were injected intraperitoneally (i. p.) once a day 
during 4 consecutive days with 50 mg/kg bodyweight BrdU dissolved in PBS. 
After the labelling phase, mice were allowed to grow until the age of 7 weeks 
before any treatment. To prepare whole-mounts of tail epidermis, tails were 
clipped, skin was peeled from tails and incubated in 5 mM EDTA in PBS 4 h at 
37 ºC. Intact sheets of epidermis were separated from the dermis using forceps 
and fixed in 4% formaldehyde in PBS.  
Burning procedure 
For induction of burn injuries, mice were anesthetized and shaved. A brass bar 
(1 cm in cross-section) pre-heated (~95 ºC) by immersing in boiling water was 
applied on the dorsal surface of each mouse and maintained in contact with the 
skin for 5 seconds. The resulted nonlethal, partial-thickness, 2nd degree burns 
measured approximately 1.3-cm × 1.3-cm. For the analysis of proliferating cells 
around the wound, animals received 2 sequential i. p. injections of 50 mg/kg 
bodyweight BrdU every 12 hours, starting 4 h after mALA-PT. 
Photodynamic treatments 
All experiments were performed during the refractory telogen phase of the hair 
follicle growth cycle  (7-week-old mice). For photodynamic treatments, mALA as 
topical cream (Metvix®, Galderma) was used. For tail skin experiments, Metvix® 
was applied directly on the skin. For back skin treatments, animals were 
completely shaved with a hair clipper and depilatory cream (Veet®) and washed 
with PBS. We applied 25 mg of Metvix® covering the area of interest. After 2.5 h 
of incubation in darkness, animals were anesthetized and the accumulation of 
PpIX was evaluated in situ by measuring the characteristic red fluorescence 
under 407 nm blue light excitation. To conduct the photodynamic treatments 
(mALA+Light), a red light (636 nm) emission was subsequently applied on the 
dorsal surface of the tissue to a total dose of 2.5- 10 J/cm2, using a LED lamp 
(Aktilite®). Light control animals received only red light, while Dark control 
animals received only mALA and they were kept in dark at least 48 h after the 
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treatment. For inhibitory experiments using ascorbic acid (AA, from Sigma), two 
doses of 100 mg/ml AA in 50% ethanol spaced 30 min were topically applied on 
the skin between the application of mALA and red light irradiation. For the 
alternative experiments using N-acetylcysteine (NAC, from Sigma), a solution 
containing 20 mg/ml NAC in PBS was i.p. inoculated daily during 5 days at a 
dose of 100 mg/kg bodyweight, until the day that mALA-PT was applied. 
Photodynamic treatments on burned skin were performed 24 h after the burning 
procedure. In all cases, the % of animals showing hair growth acceleration in 
treated back skin regions as compared to control regions in the same animal 
was evaluated. An animal showing hair growth acceleration was defined as an 
animal showing full hair growth all along the treated region, typically by days 12-
19 after shaving, but only limited or no hair growth in the control region.    
Monitoring ROS production 
ROS production in tail skin was evaluated ex vivo using hydroethidine (Sigma-
Aldrich), which reacts with ROS to produce fluorescent dye hET. Samples were 
incubated at 37 ºC for 3 h in a solution with 5 mM EDTA in PBS, containing 2 
mM mALA in the case of treated samples. Hydroethidine was added to a final 
concentration of 3.2 µM. After 1 h, the skin was irradiated with 10 J/cm2 of 636 
nm light and fixed.  
For in vivo detection of ROS produced in back skin during photodynamic 
treatment, the ROS sensitive DHF-DA (Sigma-Aldrich) was used. In order to 
assess the inhibitory effect of AA, two independent groups of animals were 
established for each time point for normalizing the obtained signal 
(mALA+Light/Light) with respect to AA-animals. After dorsal skin shaving and 
PT treatment application as previously described (Metvix® 2.5 h in dark followed 
by the irradiation with 2.5 J/cm2 of 636 nm light), 1 mg/ml DHF-DA in 50% 
ethanol was topically applied on the tissue at different time points after the 
irradiation (5, 20 and 100 min). ROS levels generated in the skin were 
determined 45 min after the application of DHF-DA in all cases, using an IVIS® 
Lumina 2 imaging system (Xenogen), by measuring the fluorescent signal 
emitted by the fluorescein produced through the oxidation of DHF-DA. The 
filters setting were 445-490 nm for the excitation and 515-575 nm for the 
emission.  
Immunological and histological methods 
Primary antibodies used were FITC-conjugated mouse monoclonal anti BrdU 
(Roche); rabbit monoclonal antibodies against Src, Phospho-Src (Tyr416), AKT, 
Phospho-AKT (Ser473), p38 MAPK, Phospho-p38 MAPK (Thr180/Tyr182), 
p44/42 MAPK, Phospho-p44/42 MAPK (Thr202/Tyr204), Phospho SAPK/JNK 
(Thr183/Tyr185) and gammaH2AX (Ser 139) and Lef1 (all from Cell Signaling 
Technologies); rabbit monoclonal anti Ki67 (Neo Markers); rabbit polyclonal anti 
Src (Abcam); mouse monoclonal anti β-catenin (BD); mouse monoclonal anti 
Active-β-catenin (Millipore); goat polyclonal anti-Proliferin 2 (Prl2c3) and 
anti-MPO (both from Santa Cruz Biotechnology); mouse monoclonal antibodies 
against PCNA (Calbiochem), tubulin and BrdU (both from Sigma). 
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For BrdU-FITC immunostaining in tail skin epithelium whole-mounts, fixed 
epidermal pieces were sequentially treated with 1 N HCl 45 min at 37 ºC, Tris-
borate-EDTA 5 min at RT and washed abundantly with distilled water. 
Permeabilization and blocking were carried out by incubation with PTG buffer 
(PBS containing 0.5% Triton X-100 and 0.2% gelatin) for 30 min at RT. Then, 
samples were incubated with the FITC-conjugated primary antibody against 
BrdU (Roche) diluted 1:50 in PBS, overnight at 37 ºC. For fluorescence 
immunostaining of pH2AX, positive control samples were obtained from animals 
exposed to a total dose of 7.44 J/cm2 of UVB light, using a lamp with a 312 nm 
emission peak (Philips TL UV). Apoptosis was detected in whole-mounts using 
the TUNEL detection kit (Roche) following the instructions of the manufacturer. 
Images were obtained in Leica TCS SP2 AOBS spectral confocal microscope 
and processed using FIJI software. 
For immunohistochemical staining, hydrated paraffin samples were treated with 
tripsin (Thermo Scientific) 30 min at 37 ºC before incubating overnight with 
primary antibodies and revealed using the Envision Flex/HRP (Dako) secondary 
antibodies cocktail and DAB kit (Vector Laboratories). 
For immunobloting, skin samples were homogenized at 4 ºC in cold NT lysis 
buffer (50 mM Tris-HCl, pH 7.4, 100 mM NaCl, 5 mM MgCl2, 5 mM CaCl2, 1% 
NP-40, 1% Triton X-100, 2 mM, PMSF, 20 µg/ml aprotinin and 1 mM sodium 
orthovanadate). 
RNA extraction and gene expression analysis 
RNA was isolated form back skin and back and tail epidermis with TriPureTM 
Isolation Reagent (Roche) and RNeasy Mini kit (QIAGEN). Gene expression 
signatures were characterized using standardized mouse global mRNA 
expression arrays (Agilent Technologies; Agilent.SingleColor.14868). Gene 
expression analysis included pool samples (n=3) obtained 2 days after the 
treatment. Pools prepared from both back and tail epidermis were 
independently analysed. Large-scale gene expression results were validated by 
real-time quantitative RT-PCR (qRT-PCR) in back skin samples. Primer 
sequences are available upon request. 
Statistical analysis 
Quantifications of LRC and Krt1-15-GFP expression in the bulge region were 
performed on confocal images (30 hair follicles/animal, 3 animals/group). BrdU 
positive cells were quantified in the 3 hair follicles closest to the burned area in 
3 different animals per condition. Comparisons between groups were performed 
by Student’s t test using the SPSS 15.0 software. Skin thickness was measured 
in 10 different regions of interfollicular epidermis per mouse including 3 animals 
per condition.  
In vivo ROS production detected with the IVIS® Lumina 2 was quantified using 
FIJI software. The relative DHF-DA Integrated density was calculated for each 
mouse as the ratio of the integrated density obtained in mALA-treated skin 
related to Light control area. For the statistical comparison, the integrated 
density was normalized calculating the ratio (vehicle/AA) for all possible pairs 
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between AA and vehicle-treated animals for each time point. The average and 
standard error (SE) were represented and means of different time points were 
compared using ANOVA. 
For statistical analyses of gene expression data, an unpaired t-test was applied, 
setting p≤0.05 and fold change ≥2.0 as limits for significance. qRT-PCR data 
were analysed by a comparative CT method, using 18S rRNA expression as 
internal control. Gene expression fold changes were represented as the ratio 
between means of 2-∆Ct values of mALA+Light and Light control groups mean 
values. Differentially expressed genes were selected based on the Student’s t 
test comparison of means of 2-∆Ct values between both groups. 
For quantification of burn assays, day-to-day digital images were analysed. The 
unhealed area was quantified using FIJI software. The area-under-the-curve 
was calculated separately for each mouse and means were compared by the 
Student’s t test.  
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TABLE LEGENDS 
Table 1. Genes significantly up- or down-regulated 2 days after mALA-PT 
in both back and tail epidermis. The expression ratios obtained by microarray 
analysis are referred to fold changes of mRNA expression in mALA+Light as 
compared to control samples. Associated functions were extracted from UniProt 
KB. TF: transcription factor. 
 
FIGURE LEGENDS 
Figure 1. Photodynamic treatment with mALA and red light induces a 
transient production of ROS in the skin. a) Accumulation of endogenous 
PpIX after mALA topic treatment in back skin. The left side in the same animal 
was used as control. b) Left panel: PpIX-dependent ROS (mALA+Light) 
production monitored by DHF-DA. Right panel: time-course analysis of relative 
ROS production in back skin; the relative integrated density of DHF-DA 
fluorescent emission of mALA+Light versus Light regions in each animal was 
quantified at different times after irradiation and normalized as described in 
methodology. The mean +/- SE was represented (n=4 for each time point). c) 
Localization of PpIX in tail skin (fluorescence microscopy images). d) ROS 
production in tail skin after mALA+Light as revealed by hET showing an 
increased and sustained accumulation in the bulge region of the hair follicle. 
Representative confocal microscopy images (maximum projections) are shown. 
Bars: 100 µm. 
Figure 2. Switching on in situ ROS production in the skin activates stem 
cell proliferation in the hair follicle niche and promotes a transient 
proliferation of epidermal and dermal cells. a) BrdU label retaining cells 
(LRC) quantification in the hair follicle bulge region. The mean + SE (n=4) is 
represented. b) Immunological detection of the Ki67 proliferation marker in the 
hair follicle bulge region. c) Dorsal skin histological sections stained for 
inmunohistochemical detection of Ki67 (left panels) or with Masson´s trichrome 
(middle panels) showing transient effects in the skin induced by mALA+Light 
treatments, including cell proliferation, hyperplasia in the epidermis (vertical 
bars), a significant increase in dermal cellularity (squares) and strong 
cornification (arrowheads). Squares indicate equivalent areas in which cell 
numbers were quantified. Right panels show the quantification of interfollicular 
epidermis (IFE) thickness and dermal cellularity in 10 histological fields. The 
mean + SD (n=3) is represented. In a) and b) representative confocal 
microscopy images (maximum projections) of tail skin whole-mounts are shown. 
Bars: 100 µm. 
Figure 3. Switching on in situ ROS production in the skin stimulates hair 
growth. a) Top row: Induction of hair growth during the refractory telogen phase 
by mALA+Light (right side of dorsal skin) as compared to Light control region 
(left side). Bottom row: Both ROS production in the skin and the acceleration of 
hair growth induced by mALA+Light were inhibited by AA anti-oxidant 
treatment. b) Quantification of the % of animals showing accelerated hair 
growth in mALA-PT as compared to control region in the absence or presence 
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of the anti-oxidant AA (n=4 in 3 independent experiments). c) Quantification of 
the ROS production inhibition in dorsal skin induced by AA during mALA-PT  
(n=4, DHF-DA was applied 20 min after irradiation). d) Inmunohistochemical 
detection of the PCNA proliferation marker in dorsal skin histological sections 2 
days after mALA-PT showing inhibition of cell proliferation by the anti-oxidant 
AA. e) Inmunolocalization of Lef1 (arrowheads) in equivalent hair follicle whole-
length reconstructions generated from confocal microscopy images (maximum 
projections) 6 and 10 days after treatments in mALA+Light and control Light 
treated skin and in non-treated skin (normal anagen, NA). f) Dorsal skin 
histological sections stained for inmunohistochemical detection of the PCNA 
proliferation marker 10 days after mALA-PT showing extensive cell proliferation 
in different regions of growing anagen hair follicles (arrowheads).  Bars: 100 
µm. 
Figure 4. Switching on in situ ROS production in the skin accelerates burn 
healing. a) PpIX production induced by mALA in burn injured regions in treated 
animals as compared to control samples. b) Burn healing evolution in 
mALA+Light treated and control animals. c) Time-course quantification of 
burned areas (left panels) showing accelerated burn healing in mALA+Light 
treated animals; the mean +/- SE (n=4) of unhealed area is represented. Area-
under-the-curve analysis (right panels) demonstrating statistical differences 
between both time-course curves (p ≤0.06). d) Histological images showing 
BrdU staining of proliferating cells in the bulge region (arrowheads) of hair 
follicles located in the adjacent area of the burn boundary (dotted lines) in 
mALA+Light as compared to control samples. Right panels: quantification of the 
number of proliferating cells in the 3 hair follicles closest to the burn boundary. 
The mean + SE (n=3) is represented. Bar: 50 µm. 
Figure 5. Molecular signatures associated with a transient switching on of 
ROS production in the skin. a) Immunoblot analysis showing a transient 
phosphorylation of Src kinase in mALA+Light as compared to Light control 
samples in back skin. b) Transient Src kinase accumulation in the epidermis of 
mALA+Light samples. c) Quantitative analysis of mRNA expression levels of the 
indicated genes in back skin. Fold change represents relative expression in 
mALA+Light with respect to control samples (*** p ≤0.001, ** p ≤0.05, *p≤0.1). 
d) Increased expression and nuclear translocation of Prl2c3 2 days after 
mALA+Light treatments. Inserts are detailed views of the nuclear distribution of 
Prl2c3 in epidermal keratinocytes. b) and d) correspond to representative 
confocal microscopy images (maximum projections). Bars: 50 µm. 
 
SUPPLEMENTARY FIGURE LEGENDS 
Figure S1. Photodynamic production of ROS using the heme biosynthetic 
pathway. a) Schematic representation of photochemical reactions during typical 
photodynamic treatments. Upon absorption of light with the appropriate λ, a 
photosensitizer molecule (PS) in the ground state S0 undergoes a transition to 
an excited singlet state S1. Since any excited state is energetically less 
preferable than the ground state, the molecule returns to S0 after a short period 
of time. Most PS have a high quantum efficiency for the transition from S1 to the 
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triplet state T1, generally characterized by a relative long lifetime. Activated PS 
in the excited triplet state can react with other molecules via two different 
pathways. Type I photochemical reaction means the transfer of electrons to 
adjacent molecules to form radical species; these radicals are likely to react 
with molecular oxygen to produce ROS, including superoxide anion (•O2-), 
hydrogen peroxide (H2O2) and hydroxyl radical (•OH). Type II photochemical 
reaction represents the dominant process for most PS employed in PDT. During 
this reaction, the transfer of energy (not electrons) to molecular oxygen (whose 
configuration in the ground state is the triplet, 3O2) drives the formation of the 
non-radical but highly reactive singlet oxygen (1O2). The photoproducts formed 
during these reactions trigger a cascade of biochemical events resulting in an 
oxidative stress that finally causes cell death or that can potentially stimulate 
cell growth. b) 5-aminolevulinic acid (ALA) is a natural precursor in the heme 
biosynthetic pathway, which involves both mitochondrial and cytosolic cellular 
compartments. The ALA synthase enzyme activity is regulated by a negative 
feedback control whereby free heme, the final product of this pathway, inhibits 
the synthesis of ALA from glycine and succinyl CoA. The administration of 
exogenous ALA or its derivative methyl aminolevulinate (mALA) bypasses the 
regulatory feedback system, so that downstream metabolites, especially 
Protoporphyrin IX (PpIX), are accumulated in the cell inducing 
photosensitization. The rate-limiting characteristics of ferrochelatase, catalyst 
enzyme of the iron insertion in PpIX, promote the accumulation of this 
endogenous PS compound.  
Figure S2. Switching on in situ ROS production in the skin does not 
induce molecular markers associated with DNA damage or apoptosis. a) 
Immunolocalization of the pH2AX protein on tail skin samples irradiated with 
312 nm light (UV), 636 nm red light (Light control) or treated with mALA+ red 
light (mALA+Light). Extensive formation of pH2AX nuclear foci in interfollicular 
epithelium cells was observed in UV treated samples but not in Light control or 
mALA+Light samples. b) Detection of apoptotic cells by TUNEL on tail skin in 
Light control samples from 15 hours to 6 days after mALA+Light. No significant 
differences in the number of apoptotic cells were observed after mALA+Light 
treatments as compared to control samples. In all cases are shown 
representative confocal microscopy images (maximum projections) 
corresponding to whole-mounts of tail skin epidermis. Bars: 50 µm.   
Figure S3. Switching on in situ ROS production in the skin activates stem 
cell proliferation in the hair follicle niche. Detection and quantification of 
cells expressing GFP under the control of the keratin1-15 promoter (Krt1-15-
GFP), a marker of epidermal stem cells, in the bulge region of the hair follicle. 
Tail skin samples were obtained 2 (a) or 6 (b) days after Light and mALA+Light 
treatments. The integrated density of GFP expression in the bulge region from 
at least 30 hair follicles in three different mice was calculated as described in 
Materials and Methods, and the mean +/- SE is represented. Images 
correspond to maximum projections of confocal microscopy reconstructions 
from tail skin whole-mounts. Bar: 100 µm. 
Figure S4. Switching on in situ ROS production in the skin promotes a 
transient proliferation of epidermal and dermal cells. Inmunohistochemical 
detection in dorsal skin histological sections of the PCNA proliferation marker 
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(a) and the Myeloperoxidase (MPO) inflammation marker (b) 1, 2 or 6 days after 
mALA+Light treatments. Sections of mouse lung were used as positive control 
for MPO expression (arrowhead). Bars: 100 µm. 
Figure S5. Switching on in situ ROS production in the skin stimulates hair 
growth and promotes a transient hyperplasia in the skin. a) Representative 
images of a mouse shaved in left and right independent regions of dorsal skin. 
Left area was the Light control skin in which no mALA was applied. Right area 
was the mALA-treated skin, which produced PpIX. Treatments were performed 
in the presence or absence of the i.p. inoculated anti-oxidant NAC. Upper 
panels: in the absence of NAC, abundant hair growth was observed between 
days 14 and 19 in the mALA+Light treated dorsal skin. No traces of hair growth 
were observed in the Light control skin. Lower panels: in the presence of NAC, 
the stimulatory effect of mALA-PT on hair growth was inhibited. Right panel: 
quantification of the % of animals showing accelerated hair growth in mALA-PT 
as compared to control region in the absence (n=8 in 4 independent 
experiments) or presence (n=2 in 4 independent experiments) of the anti-
oxidant NAC.  b) Histological sections stained with Haematoxylin/Eosin of Light 
control or mALA+Light skin samples obtained 10 days after the treatment. 
Anagen hair follicles were extensively formed after mALA-PT. Bars: 100 µm. c) 
Histological sections stained with Haematoxylin/Eosin showing a strong 
hyperplasia in the epidermis 2 days after mALA-PT that completely disappeared 
by day 6. Lower panels are detailed views on the regions indicated in upper 
panels. b) and c) correspond to experiments in the absence of NAC. Bars: 20 
µm. 
Figure S6. Switching on in situ ROS production in the skin does not 
promote the nuclear translocation of β-catenin in epidermal cells and 
does not activate p38, p44/42 or JNK mitogen-activated protein kinases 
(MAPK) signalling pathways. a) Representative confocal microscopy images 
(maximum projections) showing the immunolocalization of β-catenin on back 
skin histological sections. A strong hyperplasia but no nuclear translocation of 
β-catenin can be observed in mALA+Light treated samples as compared to 
Light control samples. Bars: 50 µm. b) Immunoblot analysis of the indicated 
proteins in back skin samples showing no significant changes induced by 
mALA-PT in the phosphorylation levels on Thr180/Tyr182 of p38, 
Thr202/Tyr204 of p44/42 or Thr138/Tyr185 of JNK. 
 





 Gene Access Nº 
GenBank 
Expressio
n ratio 
Associated functions 
Prl2c3 NM_011118 (+) 144.93 Hormone-like growth factor. Putative role in wound 
healing and hair follicle cycle. 
S100a8 NM_013650 (+) 25.55 Calcium- and zinc-binding protein which has a wide 
plethora of intra- and extracellular functions, including 
the modulation of the NADPH-oxidase activity  and a 
role as an oxidant scavenger, respectively. 
Gsta4 NM_010357 (+) 21.24  Conjugation of reduced glutathione to a wide number 
of exogenous and endogenous hydrophobic 
electrophiles. 
Hip1 NM_146001 (+) 16.78  Plays a role in clathrin-mediated endocytosis and 
trafficking. Proapoptotic protein. May be required for 
differentiation, proliferation, and/or survival of somatic 
and germline progenitors. 
Sox5 NM_011444 (+) 11.73 TF that plays a role in cell lineage establishment 
during the development. 
Fgf7 (Kgf) NM_008008 (+) 4.40 Growth factor active on keratinocytes. Important role 
in the regulation of cell proliferation and 
differentiation. 
Lef1 NM_010703 (+) 3.81 Participates in the Wnt signaling pathway. May play a 
role in hair cell differentiation and follicle 
morphogenesis. 
Lrp1 NM_008512 (+) 3.15 Endocytic receptor involved in endocytosis and in 
phagocytosis of apoptotic cells. May modulate cellular 
events, such as kinase-dependent intracellular 
signaling. 
Tln2 NM_001081242 (+) 3.11 Major component of focal adhesion plaques that links 
integrin to the actin cytoskeleton. 
Gapdh NM_008084 (+) 3.07 Has both glyceraldehyde-3-phosphate 
dehydrogenase and nitrosylase activities, thereby 
playing a role in glycolysis and nuclear functions, 
respectively. 
Myh4 NM_010855 (+) 2.79 Muscle contraction. 
Fgf18 NM_008005 (+) 2.38 Important role in the regulation of cell proliferation, 
cell differentiation and cell migration. Stimulates 
hepatic and intestinal proliferation. 
Cdh11 NM_009866 (-) 2.62 Calcium-dependent cell adhesion protein (homophilic 
interactions). 
Bmp2 NM_007553 (-) 3.14 Induces cartilage and bone formation. 
Notch2 NM_010928 (-) 3.14 Functions as a receptor for membrane-bound ligands 
Jagged1, Jagged2 and Delta1 to regulate cell-fate 
determination. 
Rora NM_013646 (-) 3.16 Orphan nuclear receptor. Regulates a number of 
genes involved in lipid metabolism, in cerebellum and 
photoreceptor development in circadian rhythm and 
skeletal muscle development. 
Myc NM_010849 (-) 3.31 TF involved in the regulation of cell proliferation and 
cell differentiation of stem cells. 
Mest NM_008590 (-) 4.31 Belongs to the AB hydrolase superfamily. Expressed 
in mesodermal tissues. 
Pcaf AF254442 (-) 4.35 Functions as a histone acetyltransferase (HAT) to 
promote transcriptional activation. 
Ikzf4 NM_011772 (-) 5.03 DNA-binding protein that binds to the 
5'GGGAATRCC-3' Ikaros-binding sequence. Interacts 
with SPI1 and MITF. 
 
Table 1. Carrasco et al. 2015 
ab
Figure S1. Carrasco et al. 2015
Control
mALA+Light (2d)
TUNEL
DAPI
b
mALA+Light (6d)
a
Light mALA +LightUV
Figure S2. Carrasco et al. 2015
D
A
P
I
p
H
2
A
X
mALA+Light (15h) mALA+Light (24h)
02
4
6
8
10
K
rt
1
-1
5
-G
F
P
 b
u
lg
e
  
e
x
p
re
s
s
io
n
 (
A
. 
U
.)
Krt1-15-GFP
L
ig
h
t 
(2
d
)
Krt1-15-GFP + DAPI
0
2
4
6
8
10
Krt1-15-GFP Krt1-15-GFP + DAPI
m
A
L
A
 +
 L
ig
h
t 
(2
d
)
L
ig
h
t 
(6
d
)
m
A
L
A
 +
 L
ig
h
t 
(6
d
)
K
rt
1
-1
5
-G
F
P
 b
u
lg
e
  
e
x
p
re
s
s
io
n
 (
A
. 
U
.)
**
a
b
Figure S3. Carrasco et al. 2015
ab
Light mALA + Light
Light (2d) mALA + Light (2d)
1d
2d
6d
Lung
Figure S4. Carrasco et al. 2015
P
C
N
A
P
C
N
A
P
C
N
A
M
P
O
ab
Figure S5. Carrasco et al. 2015
Control mALA+Light (2d) mALA+Light (6d)
c
Light (10d) mALA+Light (10d)
-
N
A
C
+
N
A
C
NAC
8d 16d 26d
PpIX
8d 16d







		




	




	

	





0
20
40
60
80
100
79.7%
12.5%
**
Figure S6. Carrasco et al. 2015
L
ig
h
t 
(2
d
)
m
A
L
A
+
L
ig
h
t 
(2
d
)
-catenin + DAPI-catenin
P-p38 (Thr180/Tyr182)
p38
P-p44/42 (Thr202/Tyr204)
p44/42
P-JNK (Thr138/Tyr185)
Tubulin
a
b
